LMO1 and LMO2 expression is dysregulated by multiple mechanisms in T-cell acute lymphoblastic leukemia (reviewed in [15, 16]), LMO2 is overexpressed in prostate cancer [17], and LMO3 is upregulated in neuroblastoma [18]. The gene discussed is LMO2; the disease is prostate carcinoma.